| human | Q5 |
| P496 | ORCID iD | 0000-0001-8650-5250 |
| P69 | educated at | Institute of Microbial Technology | Q6040614 |
| P108 | employer | Johns Hopkins University | Q193727 |
| Johns Hopkins School of Medicine | Q858729 | ||
| Howard Hughes Medical Institute | Q1512226 | ||
| Jamia Hamdard | Q6146410 | ||
| CytomX Therapeutics (United States) | Q30265385 | ||
| P106 | occupation | researcher | Q1650915 |
| Q27666538 | Crystal structure analysis of icosahedral lumazine synthase from Salmonella typhimurium, an antibacterial drug target |
| Q40364271 | Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase |
| Q38677546 | LdtMav2, a nonclassical transpeptidase and susceptibility of Mycobacterium avium to carbapenems |
| Q39030679 | Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis |
| Q48318081 | Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins. |
| Q33814192 | Non-classical transpeptidases yield insight into new antibacterials |
| Q27664233 | Potential anti-bacterial drug target: structural characterization of 3,4-dihydroxy-2-butanone-4-phosphate synthase from Salmonella typhimurium LT2 |
| Q36160654 | Role of a non-canonical surface of Rad6 in ubiquitin conjugating activity. |
| Q33730985 | Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem. |
| Q41087270 | Structure of the yeast Bre1 RING domain. |
| Q43962879 | The crystal structure reveals the molecular mechanism of bifunctional 3,4-dihydroxy-2-butanone 4-phosphate synthase/GTP cyclohydrolase II (Rv1415) from Mycobacterium tuberculosis. |
Search more.